Skip to main content
Caplight Logo









Lumox

Lumox

Private
UtrechtHealthcare & Life Scienceshttps://www.lumoxbiotech.com/

Last Round

Grant

Jul 16, 2026

Total Funding Raised

$5.68M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Lumox is a biotechnology company that develops targeted photodynamic therapeutics for the selective destruction of cancer cells.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnanobody engineeringphotodynamic therapytPDTcancer therapeuticsdrug discoveryclinical oncologymolecular biologybiotech spin-offtherapeutic platformoncology pipelinelab equipmentdiagnostic hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lumox Comparables

Compare Lumox with similar companies based on industry and business-model similarity.

Lumox comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cortalix B.V.
44%
Modulight Oyj
41%
GenLumina
39%

Lumox Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 16, 2026
GrantJun 12, 2026
GrantSep 12, 2025
GrantJun 24, 2025
GrantOct 8, 2024
Grant
Mar 28, 2024

Lumox Investors

Notable investors and investment history

Lumox investors
InvestorRounds
KWF Dutch Cancer SocietyGrant
Philips Innovation AwardGrant
Utrecht HoldingsGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 153% MoM.

  • Jul 16, 2026

    $5.13M grant from KWF Dutch Cancer Society

Lumox Filings

Explore SEC and related filing metadata, where available.

Lumox filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lumox's valuation, stock price, and market status.

Is Lumox a public or private company?

Lumox is a private company.

What is the current stock price of Lumox?

Lumox is a private company with no public stock price. Caplight tracks Lumox's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Lumox worth (valuation)?

Valuation information for Lumox is not publicly available.

Can I buy Lumox stock?

Lumox shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lumox's last funding round?

Lumox's most recent funding round was Grant on July 16, 2026.

Who are the main investors in Lumox?

Key investors in Lumox include KWF Dutch Cancer Society, Philips Innovation Award, Utrecht Holdings.

Will Lumox IPO soon?

No public IPO plans have been announced for Lumox.

How can I track Lumox secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lumox's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUtrecht
Employee Range3
Year Founded2025
Last FundingJul 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?